GlareP, MillerJ, NikolovaT, TickooR: Treating nausea and vomiting in palliative care: A review. Clin Interv Aging, 2011; 6:243–259.
2.
OkamotoY, TsunetoS, MatsudaY, InoueT, TanimukaiH, TazumiK, OnoY, KurokawaN, UekimaE: A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients. J Pain Symptom Manage, 2000; 34:217–222.
3.
PassikSD, LundbergJ, KirshKL, TheobaldD, DonaghyK, HoltsclawBA, CooperM, DuganW: A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage, 2003; 23:526–532.
4.
VigS, SeibertL, GreenMR: Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity. J Cancer Res Clin Oncol, 2014; 140:77–82.
5.
JacksonWC, TavernierL:. Olanzapine for intractable nausea in palliative care patients. J Palliat Med, 2003; 6:251–255.
